Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6428 | 1484 | 25.9 | 54% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
230 | 3 | P GLYCOPROTEIN//FMO3//TRIMETHYLAMINURIA | 49374 |
1171 | 2 | JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS//JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS//NONMEM | 9352 |
6428 | 1 | FAMOTIDINE//RANITIDINE//RANITIDINE HYDROCHLORIDE | 1484 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FAMOTIDINE | authKW | 292585 | 5% | 19% | 76 |
2 | RANITIDINE | authKW | 228859 | 6% | 12% | 93 |
3 | RANITIDINE HYDROCHLORIDE | authKW | 96585 | 1% | 26% | 18 |
4 | CIMETIDINE | authKW | 90645 | 4% | 8% | 56 |
5 | NIZATIDINE | authKW | 83098 | 1% | 20% | 20 |
6 | RANITIDINE DETERMINATION | authKW | 61724 | 0% | 100% | 3 |
7 | DISCONTINUOUS ABSORPTION | authKW | 41149 | 0% | 100% | 2 |
8 | VIERORDT METHOD | authKW | 41149 | 0% | 100% | 2 |
9 | DOUBLE PEAKS | authKW | 37026 | 0% | 30% | 6 |
10 | LONG TERM PH METRY | authKW | 27432 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 13557 | 55% | 0% | 822 |
2 | Chemistry, Analytical | 1257 | 14% | 0% | 203 |
3 | Gastroenterology & Hepatology | 667 | 7% | 0% | 106 |
4 | Medicine, General & Internal | 358 | 9% | 0% | 130 |
5 | Chemistry, Medicinal | 257 | 5% | 0% | 69 |
6 | Toxicology | 224 | 4% | 0% | 66 |
7 | Biochemical Research Methods | 169 | 5% | 0% | 67 |
8 | Chemistry, Multidisciplinary | 93 | 8% | 0% | 123 |
9 | Anesthesiology | 90 | 2% | 0% | 27 |
10 | Medical Laboratory Technology | 42 | 1% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CENT CIENCIAS EXATAS TECNOL | 20575 | 0% | 100% | 1 |
2 | CHILDRENS MEDICINES GRP | 20575 | 0% | 100% | 1 |
3 | CHIM ANALYT ELE OCHIM ORGAN 04UR12 01 | 20575 | 0% | 100% | 1 |
4 | CIC INSERM 1436 MED HOSP UNIV | 20575 | 0% | 100% | 1 |
5 | DURANGO UNIT | 20575 | 0% | 100% | 1 |
6 | FAMILY HLTH PROGRAM INC | 20575 | 0% | 100% | 1 |
7 | GLAXOSMITHKLINE CLIN PHARMACOL UNIT | 20575 | 0% | 100% | 1 |
8 | GOOD CLIN PRACT | 20575 | 0% | 100% | 1 |
9 | INVEST SOBRE PORFIRINAS PORFINIAS | 20575 | 0% | 100% | 1 |
10 | IPN DURANGO | 20575 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 16303 | 5% | 1% | 75 |
2 | PHARMACY INTERNATIONAL | 10503 | 1% | 3% | 16 |
3 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 9997 | 4% | 1% | 63 |
4 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 9860 | 4% | 1% | 53 |
5 | JOURNAL OF CLINICAL PHARMACOLOGY | 7614 | 3% | 1% | 45 |
6 | CLINICAL PHARMACOKINETICS | 6809 | 2% | 1% | 28 |
7 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 5363 | 2% | 1% | 32 |
8 | DRUG INTELLIGENCE & CLINICAL PHARMACY | 4722 | 1% | 1% | 16 |
9 | BIOPHARMACEUTICS & DRUG DISPOSITION | 4677 | 1% | 1% | 21 |
10 | CLINICAL PHARMACY | 4514 | 1% | 2% | 13 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FAMOTIDINE | 292585 | 5% | 19% | 76 | Search FAMOTIDINE | Search FAMOTIDINE |
2 | RANITIDINE | 228859 | 6% | 12% | 93 | Search RANITIDINE | Search RANITIDINE |
3 | RANITIDINE HYDROCHLORIDE | 96585 | 1% | 26% | 18 | Search RANITIDINE+HYDROCHLORIDE | Search RANITIDINE+HYDROCHLORIDE |
4 | CIMETIDINE | 90645 | 4% | 8% | 56 | Search CIMETIDINE | Search CIMETIDINE |
5 | NIZATIDINE | 83098 | 1% | 20% | 20 | Search NIZATIDINE | Search NIZATIDINE |
6 | RANITIDINE DETERMINATION | 61724 | 0% | 100% | 3 | Search RANITIDINE+DETERMINATION | Search RANITIDINE+DETERMINATION |
7 | DISCONTINUOUS ABSORPTION | 41149 | 0% | 100% | 2 | Search DISCONTINUOUS+ABSORPTION | Search DISCONTINUOUS+ABSORPTION |
8 | VIERORDT METHOD | 41149 | 0% | 100% | 2 | Search VIERORDT+METHOD | Search VIERORDT+METHOD |
9 | DOUBLE PEAKS | 37026 | 0% | 30% | 6 | Search DOUBLE+PEAKS | Search DOUBLE+PEAKS |
10 | LONG TERM PH METRY | 27432 | 0% | 67% | 2 | Search LONG+TERM+PH+METRY | Search LONG+TERM+PH+METRY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LAURITSEN, K , LAURSEN, LS , RASKMADSEN, J , (1990) CLINICAL PHARMACOKINETICS OF DRUGS USED IN THE TREATMENT OF GASTROINTESTINAL-DISEASES .2..CLINICAL PHARMACOKINETICS. VOL. 19. ISSUE 2. P. 94-125 | 264 | 53% | 30 |
2 | SOMOGYI, A , MUIRHEAD, M , (1987) PHARMACOKINETIC INTERACTIONS OF CIMETIDINE 1987.CLINICAL PHARMACOKINETICS. VOL. 12. ISSUE 5. P. 321-366 | 135 | 75% | 184 |
3 | FELDMAN, M , BURTON, ME , (1990) DRUG-THERAPY - HISTAMINE2-RECEPTOR ANTAGONISTS - STANDARD THERAPY FOR ACID-PEPTIC DISEASE .1..NEW ENGLAND JOURNAL OF MEDICINE. VOL. 323. ISSUE 24. P. 1672-1680 | 108 | 72% | 181 |
4 | SHAFI, N , SIDDIQUI, FA , NASEEM, H , SHER, N , ZUBAIR, A , HUSSAIN, A , SIAL, AA , BAIG, MT , (2013) AN OVERVIEW OF ANALYTICAL DETERMINATION OF DILTIAZEM, CIMETIDINE, RANITIDINE, AND FAMOTIDINE BY UV SPECTROPHOTOMETRY AND HPLC TECHNIQUE.JOURNAL OF CHEMISTRY. VOL. . ISSUE . P. - | 79 | 53% | 1 |
5 | POWELL, JR , DONN, KH , (1984) HISTAMINE H-2-ANTAGONIST DRUG-INTERACTIONS IN PERSPECTIVE - MECHANISTIC CONCEPTS AND CLINICAL IMPLICATIONS.AMERICAN JOURNAL OF MEDICINE. VOL. 77. ISSUE 5B. P. 57-84 | 114 | 75% | 106 |
6 | RENDIC, S , (1999) DRUG INTERACTIONS OF H-2-RECEPTOR ANTAGONISTS INVOLVING CYTOCHROME P450 (CYPS) ENZYMES: FROM THE LABORATORY TO THE CLINIC.CROATIAN MEDICAL JOURNAL. VOL. 40. ISSUE 3. P. 357 -367 | 57 | 75% | 20 |
7 | SMITH, SR , KENDALL, MJ , (1988) RANITIDINE VERSUS CIMETIDINE - A COMPARISON OF THEIR POTENTIAL TO CAUSE CLINICALLY IMPORTANT DRUG-INTERACTIONS.CLINICAL PHARMACOKINETICS. VOL. 15. ISSUE 1. P. 44-56 | 69 | 84% | 65 |
8 | MAL, F , DELCHIER, JC , (1987) HISTAMINE H-2-ANTAGONIST PHARMACOKINETIC INTERACTIONS - MECHANISMS AND CLINICAL IMPLICATIONS.GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE. VOL. 11. ISSUE 5. P. 387-398 | 83 | 81% | 6 |
9 | NEVADO, JJB , PENALVO, GC , DORADO, RMR , ROBLEDO, VR , (2013) COMPARATIVE VALIDATIONS OF NON-AQUEOUS CAPILLARY ELECTROPHORESIS AND HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY METHODS FOR THE SIMULTANEOUS DETERMINATION OF HISTAMINE H2 RECEPTOR ANTAGONISTS IN HUMAN URINE.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 921. ISSUE . P. 56-63 | 25 | 89% | 3 |
10 | MOLDOVAN, Z , ABOUL-ENEIN, HY , (2012) SPECTROPHOTOMETRIC PROCEDURE FOR INDIRECT DETERMINATION OF RANITIDINE IN PHARMACEUTICAL FORMULATION USING FLUORESCEIN SODIUM.JOURNAL OF THE IRANIAN CHEMICAL SOCIETY. VOL. 9. ISSUE 6. P. 851 -858 | 23 | 92% | 0 |
Classes with closest relation at Level 1 |